ISSN: 0443-511
e-ISSN: 2448-5667
Usuario/a
Idioma
Herramientas del artículo
Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión)
Tamaño de fuente

Open Journal Systems

Procalcitonina como predictor de sepsis en cirugía cardiovascular con circulación extracorpórea / Procalcitonin as sepsis predictor in cardiovascular surgery with cardiopulmonary bypass

Alma Ivette Carrasco-Castilla, María del Carmen Jiménez-González, Edgar Cruz-García, Gerardo Gutiérrez-Tovar, Angélica Atzin Cedillo-López, María Elena Rosalba Rodríguez-López, Iván de Jesús Ascencio-Montiel

Resumen


 

Introducción: La circulación extracorpórea durante la cirugia cardiovascular genera una respuesta exacerbada que puede asociarse con sepsis.

Objetivo: Describir la asociación entre los niveles de procalcitonina y el diagnóstico de sepsis en sujetos de cirugía cardiovascular con circulación extracorpórea.

Resumen

Métodos: se realizó un estudio de serie de casos en 142 pacientes. Los niveles de procalcitonina fueron medidos a las 24 horas y a las 72 horas después de la cirugía. Para evaluar la asociación entre los niveles de procalcitonina y la identificación de sepsis, se calculó el área bajo la curva (AUC) y la sensibilidad y especificidad identificando el mejor punto de corte.

Resultados: de un total de 142 pacientes estudiados, 7 desarrollaron sepsis (4.9%). En los niveles de procalcitonina en las 24 horas, el AUC fue de 0.921 y el mejor punto de corte fue 3.8 ng/ml (sensibilidad de 0.857 y especificidad de 0.904). En el caso de los niveles de procalcitonina a las 72 horas, observamos un AUC de 0.868 y el mejor punto de corte fue 8.4 ng/mL (sensibilidad 0.86 y especificidad 0.97).

Conclusiones: los niveles de procalcitonina a las 24 y 72 horas de la cirugía cardiovascular con circulación extracorpórea, se asociaron con la presencia de sepsis con los puntos de corte de 3.8 ng/ml y 8.4 ng/mL respectivamente.

 

Abstract

Background: Cardiopulmonary bypass generates an exacerbated response that may lead to sepsis.

Objective: To describe the association between procalcitonin levels and sepsis diagnosis in cardiovascular surgery subjects with cardiopulmonary bypass.

Material and methods: A case-series study was conducted in 142 patients. Serum procalcitonin levels were measured at 24 hours and at 72 hours after surgery using a point of care testing based on quantitative immunochromatographic method. To assess association between procalcitonin levels and sepsis status, we calculated area under the curve (AUC) and sensitivity, specificity, and predictive values for the best cut-off point.

Results: From 142 patients studied, 7 developed sepsis after surgery (4.9%). For 24-hours procalcitonin levels AUC was 0.921 and best cut-off point was 3.8 ng/mL (sensitivity 0.857 and specificity 0.904). In the case of 72-hours procalcitonin levels, we observed a value of 0.868 for AUC and best cut-off point was 8.4 ng/mL (sensitivity 0.86 and specificity 0.97).

Conclusions: Procalcitonin levels at 24 and 72 hours after cardiovascular surgery with cardiopulmonary bypass are associated with sepsis presence at cut-off points of 3.8 and 8.4 ng/mL respectively.


Palabras clave


Polipéptido alfa Relacionado con Calcitonina; Sepsis; Cirugía Torácica; Puente Cardiopulmonar / Procalcitonin; Sepsis; Thoracic Surgery; Cardiopulmonary Bypass

Texto completo:

PDF

Referencias


Evora PRB, Tenório DF, Braile DM. Is the Cardiopulmonary Bypass Systemic Inflammatory Response Overestimated? Braz J Cardiovasc Surg. 2018 Jul-Aug;33(4):I-III. doi: 10.21470/1678-9741-2018-0605. PMID: 30184025; PMCID: PMC6122753.

Parli SE, Trivedi G, Woodworth A, Chang PK. Procalcitonin: Usefulness in Acute Care Surgery and Trauma. Surg Infect (Larchmt). 2018 Feb/Mar;19(2):131-136. doi: 10.1089/ sur.2017.307. Epub 2018 Jan 22. PMID: 29356604.

Wilczyński M, Krejca M, Stepinski P, Rozalski M, Golanski J. Platelet reactivity expressed as a novel platelet reactivity score is associated with higher inflammatory state after coronary artery bypass grafting. Arch Med Sci. 2019 Dec 12;19(2):392- 400. doi: 10.5114/aoms.2019.90470. PMID: 37034540; PMCID: PMC10074322.

Rantanen M, Yousif R, Kallioinen M, Hynninen VV, Peltoniemi M, Söderholm O, Saarikoski T, Anttila V, Aittokallio J. Retrospective observational analysis of a coronary artery bypass grafting surgery patient cohort: Off-pump versus on-pump. Ann Med Surg (Lond). 2022 Nov 9;84:104812. doi: 10.1016/j. amsu.2022.104812. PMID: 36536727; PMCID: PMC9758289.

Squiccimarro E, Stasi A, Lorusso R, Paparella D. Narrative review of the systemic inflammatory reaction to cardiac surgery and cardiopulmonary bypass. Artif Organs. 2022 Apr;46(4):568-577. doi: 10.1111/aor.14171. Epub 2022 Jan 21. PMID: 35061922; PMCID: PMC9303696.

Squiccimarro E, Labriola C, Malvindi PG, Margari V, Guida P, Visicchio G, Kounakis G, Favale A, Dambruoso P, Mastrototaro G, Lorusso R, Paparella D. Prevalence and Clinical Impact of Systemic Inflammatory Reaction After Cardiac Surgery. J Cardiothorac Vasc Anesth. 2019 Jun;33(6):1682- 1690. doi: 10.1053/j.jvca.2019.01.043. Epub 2019 Jan 17. PMID: 30772177.

Mejia OAV, Borgomoni GB, Palma Dallan LR, Mioto BM, Duenhas Accorsi TA, Lima EG, de Matos Soeiro A, Lima FG, Manuel de Almeida Brandão C, Alberto Pomerantzeff PM, Oliveira Dallan LA, Ferreira Lisboa LA, Jatene FB. Quality improvement program in Latin America decreases mortality after cardiac surgery: a before-after intervention study. Int J Surg. 2022 Oct;106:106931. doi: 10.1016/j.ijsu.2022.106931. Epub 2022 Sep 17. PMID: 36126857.

Bhende VV, Pathan SR, Sharma TS, Kumar A, Majmudar HP, Patel VA. Risk factors of sepsis and prevalence of multidrug resistant organisms in pediatric cardiac surgery in tertiary care teaching rural hospital in India: A retrospective observational study. Health Sci Rep. 2023 Apr 15;6(4):e1191. doi: 10.1002/ hsr2.1191. PMID: 37073300; PMCID: PMC10105830.

Bösch F, Angele MK, Chaudry IH. Gender differences in trauma, shock and sepsis. Mil Med Res. 2018 Oct 26;5(1):35. doi: 10.1186/s40779-018-0182-5. PMID: 30360757; PMCID: PMC6203206.

Li Q, Zheng S, Zhou PY, Xiao Z, Wang R, Li J. The diagnostic accuracy of procalcitonin in infectious patients after cardiac surgery: a systematic review and meta-analysis. J Cardiovasc Med (Hagerstown). 2021 Apr 1;22(4):305-312. doi: 10.2459/JCM.0000000000001017. PMID: 33633046.

Li X, Wang X, Li S, Yan J, Li D. Diagnostic Value of Procalcitonin on Early Postoperative Infection After Pediatric Cardiac Surgery. Pediatr Crit Care Med. 2017 May;18(5):420-428. doi: 10.1097/PCC.0000000000001118. PMID: 28266954.

Basitha K, Sukardi R, Farida Soenarto R, Wardoyo S. The value of procalcitonin in systemic inflammatory response syndrome after open-heart surgery for CHD. Cardiol Young. 2019 Nov;29(11):1335-1339. doi: 10.1017/S1047951119001847. Epub 2019 Sep 23. PMID: 31543081.

Li Y, Zhang J, He Z. Early Predictive Value of Procalcitonin for the Diagnosis of Pulmonary Infections after Off-pump Coronary Artery Bypass Grafting. Heart Surg Forum. 2021 Jan 13;24(1):E004-E008. doi: 10.1532/hsf.3381. PMID: 33635256.

Wang YC, Wu HY, Luo CY, Lin TW. Cardiopulmonary Bypass Time Predicts Early Postoperative Enterobacteriaceae Blood-stream Infection. Ann Thorac Surg. 2019 May;107(5):1333- 1341. doi: 10.1016/j.athoracsur.2018.11.020. Epub 2018 Dec 12. PMID: 30552885.

Meisner M, Rauschmayer C, Schmidt J, Feyrer R, Cesnjevar R, Bredle D, Tschaikowsky K. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med. 2002 Aug;28(8):1094- 102. doi: 10.1007/s00134-002-1392-5. Epub 2002 Jul 6. PMID: 12185431.

Ding W, Liu J, Zhou X, Miao Q, Zheng H, Zhou B, Dou G, Tong Y, Long Y, Su L. Clinical Multi-Omics Study on the Gut Microbiota in Critically Ill Patients After Cardiovascular Surgery Combined With Cardiopulmonary Bypass With or Without Sepsis (MUL-GM-CSCPB Study): A Prospective Study Protocol. Front Med (Lausanne). 2020 Jul 8;7:269. doi: 10.3389/ fmed.2020.00269. PMID: 32733902; PMCID: PMC7360671.

Heredia-Rodríguez M, Bustamante-Munguira J, Lorenzo M, Gómez-Sánchez E, Álvarez FJ, Fierro I, et al. Procalcitonin and white blood cells, combined predictors of infection in cardiac surgery patients. J Surg Res. 2017 May 15;212:187- 194. doi: 10.1016/j.jss.2017.01.021. Epub 2017 Feb 1. PMID: 28550906.

Klingele M, Bomberg H, Schuster S, Schäfers HJ, Groesdonk HV. Prognostic value of procalcitonin in patients after elective cardiac surgery: a prospective cohort study. Ann Intensive Care. 2016 Dec;6(1):116. doi: 10.1186/s13613-016-0215-8. Epub 2016 Nov 23. PMID: 27878573; PMCID: PMC5120170.

Sharma P, Patel K, Baria K, Lakhia K, Malhotra A, Shah K, et al. Procalcitonin level for prediction of postoperative infection in cardiac surgery. Asian Cardiovasc Thorac Ann. 2016 May;24(4):344-9. doi: 10.1177/0218492316640953. Epub 2016 Mar 21. PMID: 27002098.

Rothenburger M, Markewitz A, Lenz T, Kaulbach HG, Marohl K, Kuhlmann WD, et al. Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein. Clin Chem Lab Med. 1999 Mar;37(3):275-9. doi: 10.1515/ CCLM.1999.048. PMID: 10353472.

Miao Q, Chen SN, Zhang HJ, Huang S, Zhang JL, Cai B, Niu Q. A Pilot Assessment on the Role of Procalcitonin Dynamic Monitoring in the Early Diagnosis of Infection Post Cardiac Surgery. Front Cardiovasc Med. 2022 Jun 2;9:834714. doi: 10.3389/ fcvm.2022.834714. PMID: 35722120; PMCID: PMC9200999.

Alghamdi BA, Alharthi RA, AlShaikh BA, Alosaimi MA, Alghamdi AY, Yusnoraini N, Almashhor A. Risk Factors for Post-cardiac Surgery Infections. Cureus. 2022 Nov 7;14(11):e31198. doi: 10.7759/cureus.31198. PMID: 36505103; PMCID: PMC9728502.

van Engelen TSR, Wiersinga WJ, Scicluna BP, van der Poll T. Biomarkers in Sepsis. Crit Care Clin. 2018 Jan;34(1):139-152. doi: 10.1016/j.ccc.2017.08.010. Epub 2017 Oct 12. PMID: 29149935. 

 Liu HH, Zhang MW, Guo JB, Li J, Su L. Procalcitonin and Creactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria. Ir J Med Sci. 2017 Feb;186(1):207-212. doi: 10.1007/s11845-016-1457-z. Epub 2016 May 2. PMID: 27139197.

Liu MH, Yu H, Zhou RH. Application of Adsorptive Blood Purification Techniques during Cardiopulmonary Bypass in Cardiac Surgery. Oxid Med Cell Longev. 2022 May 25;2022:6584631. doi: 10.1155/2022/6584631. PMID: 35663201; PMCID: PMC9159835.




DOI (PDF): https://doi.org/10.24875/10.5281/zenodo.10064366

Enlaces refback

  • No hay ningún enlace refback.